Effects of recombinant osteopontin on blood-brain barrier disruption after subarachnoid hemorrhage in rats.

Suzuki H, Hasegawa Y, Ayer R, Sugawara T, Chen W, Sozen T, Kanamaru K, Taki W, Zhang JH. Effects of recombinant osteopontin on blood-brain barrier disruption after subarachnoid hemorrhage in rats. Acta Neurochir Suppl. 2011; 111:231-6.

View in: PubMed

subject areas

Animals
Blood-Brain Barrier
Brain Edema
Chi-Square Distribution
Disease Models, Animal
Dose-Response Relationship, Drug
Gene Expression Regulation
I-kappa B Kinase
Male
MAP Kinase Kinase 4
Matrix Metalloproteinase 9
Nervous System Diseases
Neurologic Examination
Oligopeptides
Osteopontin
Rats
Rats, Sprague-Dawley
Recombinant Proteins
Severity of Illness Index
Subarachnoid Hemorrhage

authors with profiles

John Zhang

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support